NNMT and obesity due to melanocortin 4 receptor deficiency: Likewise, treatment with the selective NNMT inhibitors 5-amino-1-methylquinoline [17] or 6-methoxynicotinamide [5] resulted in reduced body weight, higher insulin sensitivity, and improved glucose tolerance in mice with diet-induced obesity (Figure 1).